Michael R. Cook

Dr. Michael R. Cook is an Assistant Professor of Clinical Medicine specializing in Hematology-Oncology at the Perelman School of Medicine, University of Pennsylvania. He practices at the Abramson Cancer Center with locations at the Perelman Center for Advanced Medicine and Penn Presbyterian Medical Center, where he provides care for patients aged 18 and older with hematologic malignancies.

Dr. Cook's research focuses on advancing treatments for lymphoma, particularly through innovative approaches like CAR T-cell therapy and immune checkpoint inhibitors. His work examines treatment outcomes in CNS lymphoma, primary mediastinal B-cell lymphoma, and the impact of the tumor microenvironment on therapeutic responses. He has published numerous high-impact studies in journals including The New England Journal of Medicine, Blood, and Haematologica.

His clinical expertise encompasses the full spectrum of hematologic malignancies, with particular emphasis on lymphoma subtypes. Dr. Cook completed his medical training at Temple University School of Medicine, followed by residency and fellowship at Georgetown University Medical Center. Patient reviews consistently highlight his compassionate care, thoroughness, and exceptional communication skills, resulting in a 5.0 average rating from over 320 patient reviews.

• Active clinical researcher in hematologic malignancies
• Specialized expertise in lymphoma treatment
• Focus on immunotherapy approaches including CAR T-cell therapy
• High patient satisfaction ratings

Dr. Cook maintains active hospital privileges at both the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center, allowing him to provide comprehensive care across the Penn Medicine system. His research program bridges clinical practice and scientific discovery, contributing significantly to the advancement of treatments for blood cancers.